The Effects of Two Anesthetic Drugs on Some Enzyme Levels in Patients Undergoing Lower Extremity Surgery

A Randomized, Double-blind Comparison of the Effects of Dexmedetomidine and Ketamine on Oxidative Stress Markers in Patients Under Combined Spinal-epidural Anesthesia Under Lower Extremity Surgery

The primary aim of this study was to compare the effects of dexmedetomidine and ketamine, which are administered intravenously during surgery, on the levels of malondialdehyde, an antioxidant, anti-inflammatory enzyme, heme oxygenase-1 enzyme levels and C-reactive protein levels in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.

Study Overview

• Status: Completed
• Conditions: Malondialdehyde; C-Reactive Protein; Heme Oxygenase
• Intervention / Treatment: Other: Saline; Other: Dexmedetomidine; Other: Ketamine

Detailed Description

This study was planned as double-blind; The researcher who evaluated the patient and recorded the data did not know which group the patient belonged to. The randomization sequence was generated with a computerized random number generator and patients were assigned to 3 groups, with 30 patients in each group.

The group to which the patient was included was listed in serially numbered sealed opaque envelopes. Another investigator (not involved in this study and not blinded to group assignment) administered CSEA to patients in a sitting position and opened the envelopes to see which group the patient belonged to, and prepared and administered the drugs to be used during anesthesia. An anesthetist, blinded to the group allocation, was responsible for collecting the intraoperative data. During and after surgery, data were recorded by and by this investigator. The blood of the patients was taken by the researcher who collected the data and delivered to the researchers who made the biochemical analyzes of their blood and blinded the groups. All surgeries were performed by the same surgical team and the same anesthesia team.

Peripheral IV vascular access was established using a 16/18-gauge cannula on the day of the operation. No premedication was applied to any patient before the operation. Before the anesthesia procedure, the patients' age, weight, height, body mass indexes, american society of anesthesiologists (ASA) physical status, systolic, diastolic and mean blood pressure baseline values, heart rate and oxygen saturation levels were recorded.

CSEA was applied to all patients in the sitting position. Following skin sterilization and local anesthetic infiltration (2% lidocaine), an 18-gauge Tuohy needle (CSEA, Braun, Melsungen, Germany) was advanced along the midline L3-4 or L4-5 intervertebral spaces using a loss of resistance technique. After negative pressure was detected, a 27-gauge pen-tipped spinal needle was inserted intrathecally using the needle-through-the-needle technique. After the free cerebrospinal fluid flow was observed, 1.8 ml 0.5% isobaric bupivacaine (9 mg) and 15 µg fentanyl were administered for 30 seconds. Then, the spinal needle was removed and the catheter was inserted into the epidural space, and it was advanced 3-5 cm in the space and controlled with negative pressure, and the catheter was fixed. At the end of the anesthesia procedure, the patients were placed in the supine position for the operation. The necessary study drugs were started to be administered to the patients in accordance with the study group they were assigned to, and infusions were continued throughout the operation.

The level of sensory block was assessed with the pinprick test, and surgery was allowed when the sensory block reached the upper level of the T12-L1 dermatome. If sensory block did not occur within the first 20 minutes following the spinal injection, spinal anesthesia was considered unsuccessful and the patients were excluded from the study. The patients who were excluded from the study were injected with an additional 5 ml of 2% lidocaine solutions through the epidural catheter until the sensory block T12-L1 level was achieved, and the patients were allowed to operate.

If the intrathecal space could not be reached in three unsuccessful attempts, a general anesthesia protocol was planned and patients requiring general anesthesia were excluded from the study.

For the measurement of MDA and HO-1 levels, blood samples taken from the patient groups included in the study were taken for 10-20 minutes for clotting. After the tube was kept in an upright position, it was centrifuged at +4°C at 4000 rpm for 15 minutes. The serum samples obtained were aliquoted and placed in a deep freezer at -80˚Ϲ and kept there until the day of analysis.

Serum malondialdehyde (MDA) and HO-1 levels were measured on the same day in order not to be affected by the variation between days. Serum MDA and HO-1 levels were determined by ELISA method, using "Human MDA ELISA Kit" and Human HO-1 ELISA Kit. measured in accordance with the manufacturer's instructions.

In addition, C-reactive protein (CRP) (mg/dl), calcium (mg/dl), alkaline phosphatase (U/L), lactate dehydrogenase (U/L), aspartate aminotransferase (U/L), alanine aminotransferase, which are routinely checked at preoperative, postoperative 2nd and 24th hours. (U/L), glucose (mg/dl), potassium (nmol/L), iron (ug/dl), total protein (g/dl) and albumin (g/dl) levels in Beckman Coulter device, ferritin (ng) /ml) Beckman Coulter device, Blood count parameters, White Blood Cell Count (10^3/mcL), Total Lymphocyte Count (10^3/mcL), Hemoglobin (g/dL) were studied on Sysmex device.

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Erzurum, Turkey
    • Ataturk University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• ASA risk classification 1-2
• Patients who agreed to participate in the study

Exclusion Criteria:

• Body mass index (BMI) over 30 kg/m2
• Patients who will use bone cement in the surgical procedure
• Patients who will apply a tourniquet to the lower extremity
• Patients with vascular and coronary disease
• Patients with coagulation disorders that would prevent the application of CSEA
• Patients with allergies to the drugs to be used in the study
• Patients with increased head and intraocular pressure
• Patients with psychiatric and neuromuscular disorders
• Patients with multiple trauma
• Patients who did not consent to participate in the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Patients given saline; 10 cc/hour isotonic is given throughout the operation.	Other: Saline; We used 0.9% isotonic sodium chloride.
Active Comparator: Patients given dexmedetomidine.; Dexmedetomidine 0.1 µg/kg IV bolus followed by 0.2 µg/kg/hr infusion throughout surgery.	Other: Dexmedetomidine; We used the vial containing 200 mcg/2 ml i.v. concentrated infusion solution in 100 ml of 0.9% isotonic sodium chloride.
Active Comparator: Patients given ketamine.; Ketamine 0.2 mg/kg bolus followed by 0.1 mg/kg/hr infusion throughout surgery.	Other: Ketamine; We used 500 mg/10 ml solution for injection in 0.9% isotonic sodium chloride.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Heme Oxygenase-1	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of heme oxygenase-1, an antioxidant and anti-inflammatory enzyme, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	just before surgery
C-Reactive Protein	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on C-Reactive Protein in patients undergoing lower extremity surgery under combined spinal epidural anesthesia.	just before surgery
Malondialdehyde	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of malondialdehyde, which is an oxidative stress marker, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	2 hours after the start of surgery
Heme Oxygenase-1	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of heme oxygenase-1, an antioxidant and anti-inflammatory enzyme, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	2 hours after the start of surgery
C-Reactive Protein	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on C-Reactive Protein in patients undergoing lower extremity surgery under combined spinal epidural anesthesia.	2 hours after the start of surgery
Malondialdehyde	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of malondialdehyde, which is an oxidative stress marker, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	24 hours after surgery
Heme Oxygenase-1	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of heme oxygenase-1, an antioxidant and anti-inflammatory enzyme, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	24 hours after surgery
C-Reactive Protein	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on C-Reactive Protein in patients undergoing lower extremity surgery under combined spinal epidural anesthesia.	24 hours after surgery
Concentration of Malondialdehyde	The primary aim of this study was to investigate the effects of intravenous (iv) administration of dexmedetomidine and ketamine on the level of malondialdehyde, which is an oxidative stress marker, in patients who underwent lower extremity surgery under combined spinal epidural anesthesia.	just before surgery

Collaborators and Investigators

• Sponsor: Ataturk University
• Investigators: Principal Investigator: İrfan Uç, Research assistant

Study record dates

Study Major Dates

• Study Start (Actual): December 30, 2021
• Primary Completion (Actual): March 30, 2023
• Study Completion (Actual): May 28, 2023

Study Registration Dates

• First Submitted: June 5, 2023
• First Submitted That Met QC Criteria: July 17, 2023
• First Posted (Actual): July 18, 2023

Study Record Updates

• Last Update Posted (Actual): August 31, 2023
• Last Update Submitted That Met QC Criteria: August 29, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Keywords: Ketamine; Oxidative Stress; Dexmedetomidine; Antioxidant
• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Adrenergic Agents; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological Action; Central Nervous System Depressants; Peripheral Nervous System Agents; Analgesics; Sensory System Agents; Anesthetics, Dissociative; Anesthetics, Intravenous; Anesthetics, General; Anesthetics; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Agents; Analgesics, Non-Narcotic; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic Agonists; Hypnotics and Sedatives; Ketamine; Dexmedetomidine
• Other Study ID Numbers: B.30.2.ATA.0.01.00/23

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: we will decide later.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No